Disease-modifying therapies in multiple sclerosis in Latin America

The treatment of multiple sclerosis (MS) has become increasingly complex during the last 10 years, mainly because of the advent of new and more potent disease-modifying therapies (DMTs). In Latin America, the therapeutic repertoire available for MS treatment is similar to the one in the rest of the...

Full description

Bibliographic Details
Main Authors: Skromne-Eisenberg, Eli, Ordoñez-Boschetti, Laura, Treviño-Frenk, Irene
Format: Online Article Text
Language:English
Published: SAGE Publications 2017
Subjects:
Special Issue: MS in Latin America
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617092/
https://www.ncbi.nlm.nih.gov/pubmed/28979794
http://dx.doi.org/10.1177/2055217317723369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617092/
https://www.ncbi.nlm.nih.gov/pubmed/28979794
http://dx.doi.org/10.1177/2055217317723369

Similar Items